Noah Knauf

Noah Knauf

Noah Knauf leads investments in the firm’s digital growth practice, focusing on high-growth technology companies in a variety of sectors, including consumer, enterprise, healthcare, and financial services.

Before joining Kleiner Perkins, Noah worked for nine years at Warburg Pincus, where he led investments in technology-enabled businesses and helped deploy $1.8 billion of equity capital across 18 companies. His investments ranged from early-stage companies to large growing enterprises with thousands of employees.

Noah served on the boards of innovative growth companies such as Accriva, Constitution Medical, Helix, JHP Pharmaceuticals, N3twork, Outset, Silk Road Medical, Singular Bio, and Specialists On Call.

Earlier in his career, Noah was an investor at Parthenon Capital and a consultant at Bain & Company. Noah received a B.S.B.A in Management Information Systems and Operations Management from the University of Arizona and an M.B.A. from Stanford University’s Graduate School of Business, where he was an Arjay Miller Scholar.


Recommended Reading